HGH Therapy > Nutropin® Injections

Nutropin® is HGH for Injection produced by Genentech

Order Nutropin Human Growth Hormone Injections

Nutropin Treats HGH Hormone Imbalance or Deficiency

Fill out the Info Request Form or Call us for the Best Nutropin Pricing

Nutropin is produced using recombinant DNA technology and has the same amino acid sequence as Human Growth Hormone produced naturally in the human body. Recombinant growth hormone was cloned by Genentech scientists in 1979.

Nutropin HGH Injections are a Human Growth Hormone Therapy to treat AGHD | See the New Nuspin Nutropin HGH Shots from Genentech


Growth hormone (hGH or GH) doesn't just contribute to physical growth in children. Adults need GH, too. In adults, GH is essential to the maintenance of healthy body composition and metabolism. When an adult's body is unable to produce enough GH, he or she is said to have adult GH deficiency (AGHD).

HGH Deficiency in Adults Some people with adult growth hormone (hGH or GH) deficiency were not GH-deficient as children. These people are said to have adult-onset GH deficiency.

AGHD Onset The usual cause of adult-onset GH deficiency is damage to the pituitary gland, which is responsible for secreting GH. This damage is most commonly caused by one or more tumors in and around the pituitary. Such a tumor may compress the gland, or the damage may occur when the tumor is removed. The pituitary gland may also be damaged by infection, blood vessel disease, severe head injury, or radiation treatment for tumors of the head or neck.

Growth Hormone Deficiency Education

Growth hormone deficiency, GHD, is a pituitary disorder resulting in short stature and other physical ailments. GHD occurs when the production of growth hormone, secreted by the pituitary gland, is disrupted. Since growth hormone plays a critical role in stimulating body growth and development, and is involved in the production of muscle protein and in the breakdown of fats, a decrease in the hormone affects numerous body processes.

Turner syndrome affects approximately one in 2,500 female, live births. Turner syndrome is a chromosomal disorder that affects females exclusively and is characterized, in part, by short stature and ovarian dysfunction. It is caused by the absence of all or part of one of the X chromosomes.

Chronic renal insufficiency, CRI, affects about 3,000 children in the United States. It manifests through a gradual and progressive loss of the ability of the kidneys to excrete wastes, concentrate urine, and conserve electrolytes. Kidney transplants can help a child start growing normally again, but most children do not make up the growth lost prior to transplantation.

HGH Therapy Safety

Growth hormone should not be initiated to treat patients with acute critical illness due to complications following open heart or abdominal surgery, multiple accidental trauma or to patients having acute respiratory failure.

Growth Hormone should not be used for growth promotion in pediatric patients with closed epiphyses.Growth Hormone should not be used in patients with active neoplasia. Growth Hormone therapy should be discontinued if evidence of neoplasia develops. Patients with a history of an intracranial lesion should be examined frequently for progression or recurrence of the lesion.

Intracranial hypertension (IH) with papilledema, visual changes, headache, nausea, and/or vomiting has been reported in a small number of patients treated with Growth Hormone. Funduscopic examination of patients is recommended at the initiation and periodically during Growth Hormone therapy. Patients with CRI or Turner's Syndrome may be at increased risk for development of IH.

Growth Hormone may reduce insulin sensitivity, particularly in obese individuals, patients should be observed for evidence of glucose intolerance. For patients with diabetes mellitus, the insulin dose may require adjustment when Growth Hormone therapy is instituted.

Experience with prolonged Growth Hormone treatment in adults is limited.

Adverse events frequently reported in adult patients were edema (41%), arthralgias and other joint disorders (27%). Thirty-five percent of childhood-onset adult Growth Hormone deficient subjects treated with Growth Hormone 0.025 mg/kg/day for 2 years had supraphysiologic levels of insulin-like growth factor-I (IGF-I) at some time during the study, which may carry unknown risks. During therapy, dosage should be decreased if required by the occurrence of side effects or excessive IGF-I levels.

Patients being treated with Growth Hormone (GH) should be informed of the potential benefits and risks associated with Growth Hormone therapy.

If you need a prescription for HGH, contact our hormone treatment center for information on how to get a doctor's prescription for growth hormone injections. With your prescription you can purchase Nutropin somatropin products including Nutropin AQ Pen 10 mg, Nutropin AQ Pen 20, and Nuspin somatropin cartridges to be used in your treatment program. Where and how to get HGH prescribed by your doctor.

Where can I buy Nutropin® HGH Injections?

Buy Nutropin and Other Brands of Growth Hormone Injections

Order Norditropin Online | Order Saizen Online | Order Genotropin Online | Order Omnitrope Online | Order Humatrope Online | Order Nutropin Online

Learn more about other HGH Injection products including Sermorelin - HGH Injection Products

TRADEMARK DISCLAIMER The HGH.bz website is not associated with, endorsed by or in any way officially affiliated with with Novo Nordisk who makes the brand name of somatropin Norditropin®, Nordipen®, NordiFlex®, Nordilet®, FlexPro®, PenMate® and SimpleXx; Pfizer who makes the brand name of somatropin Genotropin® and Testosterone Cypionate Depo-Testosterone®; Eli Lilly who makes the brand name of somatropin Humatrope®; Merck EMD Serono who makes the brand name of somatropin Saizen® and Serostim®; Genentech who makes the brand name of somatropin Nutropin®, Nuspin® and NutropinAQ®; Teva who makes the brand name of somatropin Tev-Tropin®; nor Sandoz who makes the brand name of somatropin Omnitrope®.

Cenegenics® is a Trademark of Cenegenics, LLC; Mayo Clinic® is a Trademark of Mayo Foundation for Medical Education and Research; Cleveland Clinic® is a Trademark of the Cleveland Clinic Foundation.

Product names, logos, brands, logos, images and other trademarks featured or referred to within the HGH.bz website, and any mention of the above listed products and services, and discussed within, are the property of their respective trademark holders. These trademark holders are not affiliated with the Optimal Health Medical Center, our products, or our website. All product and company names, logos, brands or images, are Trademarks TM or Registered® Trademarks of their respective holders. Use of them on the Optimal Health HGH.bz website and/or on any social media forum does not imply any affiliation with or endorsement by them.


Contact Me Between:


 Reload Image